China Avian Flu Market to 2032
Overview
The China Avian Flu Market is expected to reach a 105.61 USD Million by 2032 and is projected to grow at a CAGR of 12.28% from 2025 to 2032.
Revenue, 2024 (USD Million)
46.93
Forecast, 2032 (USD Million)
105.61
CAGR, 2024 - 2032
12.28%
Report Coverage
China
China Avian Flu Market 2018-2032 USD Million
China Avian Flu Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 46.93 USD Million
- Projected Market Size (2032): 105.61 USD Million
- CAGR (2025-2032): 12.28%
Key Findings of China Avian Flu Market
- The China Avian Flu Market was valued at 46.93 USD Million in 2024.
- The China Avian Flu Market is likely to grow at a CAGR of 12.28% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Veterinary in Application Segment accounted for the largest share of the market with a revenue of 42.71 USD Million
- The fastest growing segment Gallimune/ Gallivac/ Volvac in Vaccine Segment grew Fastest with a CAGR of 13.29% during the forecast period from 2024 to 2032.
China Avian Flu Market Scope
China Avian Flu Market Segmentation & Scope
Strain
- H9 Strain
- H7 Strain
- H5 Strain
Type
- Highly Pathogenic Avian Influenza (HPAI)
- Low Pathogenic Avian Influenza (LPAI)
Vaccine
- Viraflu
- Mefluvac
- Others
- Gallimune/ Gallivac/ Volvac
Distribution Channel
- Retail Sales
- Third Party Distributor
- Direct Tenders
Vaccine Category
- DNA vaccine
- Combination Vaccines
- Live Recombinant Vaccines
- Inactivated Vaccines
Application
- Human
- Veterinary
End User
- Others
- Research Institutes
- Governmental Organizations
- Veterinary Clinics
- Poultry Farms
China Avian Flu Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 46.93 USD Million |
| Market Value in 2032 | 105.61 USD Million |
| CAGR (2025-2032) | 12.28% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Strain,Type,Vaccine,Distribution Channel,Vaccine Category,Application,End User |
Regional Insights:
-
Leading Market (2024-2032): China, leading in terms of revenue 46.93 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 46.93 USD Million in 2024.
Segments and Scope
-
China Avian Flu Market to 2032, By Strain
- H5 Strain is the largest segment in China Avian Flu Market to 2032 with a revenue of 18.98 USD Million in the year 2024.
- H5 Strain is the Fastest growing segment in China Avian Flu Market to 2032 with a Growth rate of 12.65 % in forecast period 2025-2032.
-
China Avian Flu Market to 2032, By Type
- Low Pathogenic Avian Influenza (LPAI) is the largest segment in China Avian Flu Market to 2032 with a revenue of 26.59 USD Million in the year 2024.
- Highly Pathogenic Avian Influenza (HPAI) is the Fastest growing segment in China Avian Flu Market to 2032 with a Growth rate of 12.01 % in forecast period 2025-2032.
-
China Avian Flu Market to 2032, By Vaccine
- Gallimune/ Gallivac/ Volvac is the largest segment in China Avian Flu Market to 2032 with a revenue of 20.39 USD Million in the year 2024.
- Gallimune/ Gallivac/ Volvac is the Fastest growing segment in China Avian Flu Market to 2032 with a Growth rate of 13.29 % in forecast period 2025-2032.
-
China Avian Flu Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in China Avian Flu Market to 2032 with a revenue of 21.08 USD Million in the year 2024.
- Third Party Distributor is the Fastest growing segment in China Avian Flu Market to 2032 with a Growth rate of 11.85 % in forecast period 2025-2032.
-
China Avian Flu Market to 2032, By Vaccine Category
- Inactivated Vaccines is the largest segment in China Avian Flu Market to 2032 with a revenue of 30.66 USD Million in the year 2024.
- Live Recombinant Vaccines is the Fastest growing segment in China Avian Flu Market to 2032 with a Growth rate of 12.27 % in forecast period 2025-2032.
-
China Avian Flu Market to 2032, By Application
- Veterinary is the largest segment in China Avian Flu Market to 2032 with a revenue of 42.71 USD Million in the year 2024.
- Veterinary is the Fastest growing segment in China Avian Flu Market to 2032 with a Growth rate of 12.32 % in forecast period 2025-2032.
-
China Avian Flu Market to 2032, By End User
- Poultry Farms is the largest segment in China Avian Flu Market to 2032 with a revenue of 25.97 USD Million in the year 2024.
- Veterinary Clinics is the Fastest growing segment in China Avian Flu Market to 2032 with a Growth rate of 11.98 % in forecast period 2025-2032.
China Avian Flu Market Company Share Analysis
China Avian Flu Market Geographical Sales Distribution, 2018-2032 USD Million
China Avian Flu Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The China Avian Flu Market is segmented based on Segmentation Strain,Type,Vaccine,Distribution Channel,Vaccine Category,Application,End User.
China Avian Flu Market was valued at USD 46.93(Revenue in USD Million) in 2023.
China Avian Flu Market is projected to grow at a CAGR of 12.28% during the forecast period of 2024 to 2032.
The Veterinary segment is expected to dominate the China Avian Flu Market, holding a largest market share of 42.71 USD Million in 2024
Coming Soon....
China Avian Flu Market Scope
China Avian Flu Market Segmentation & Scope
Strain
- H9 Strain
- H7 Strain
- H5 Strain
Type
- Highly Pathogenic Avian Influenza (HPAI)
- Low Pathogenic Avian Influenza (LPAI)
Vaccine
- Viraflu
- Mefluvac
- Others
- Gallimune/ Gallivac/ Volvac
Distribution Channel
- Retail Sales
- Third Party Distributor
- Direct Tenders
Vaccine Category
- DNA vaccine
- Combination Vaccines
- Live Recombinant Vaccines
- Inactivated Vaccines
Application
- Human
- Veterinary
End User
- Others
- Research Institutes
- Governmental Organizations
- Veterinary Clinics
- Poultry Farms
Frequently Asked Questions
The China Avian Flu Market is segmented based on Segmentation Strain,Type,Vaccine,Distribution Channel,Vaccine Category,Application,End User.
China Avian Flu Market was valued at USD 46.93(Revenue in USD Million) in 2023.
China Avian Flu Market is projected to grow at a CAGR of 12.28% during the forecast period of 2024 to 2032.
The estimated market value of the China Avian Flu Market for final year is USD 105.61 (USD Million).
China Avian Flu Market Company Profiling
Frequently Asked Questions
The China Avian Flu Market is segmented based on Segmentation Strain,Type,Vaccine,Distribution Channel,Vaccine Category,Application,End User.
China Avian Flu Market was valued at USD 46.93(Revenue in USD Million) in 2023.
China Avian Flu Market is projected to grow at a CAGR of 12.28% during the forecast period of 2024 to 2032.
The estimated market value of the China Avian Flu Market for final year is USD 105.61 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.